Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1.

NCT03455322 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Renal Impairment in Hepatorenal Syndrome

Interventions

DRUG: norepinephrine versus midodrine & octreotide

Sponsor

National Hepatology & Tropical Medicine Research Institute